Upregulated dynorphin opioid peptides mediate alcohol-induced learning and memory impairment

Translational Psychiatry

Volumn 3, Issue , 2013, Pages

  Kuzmin, A ^a,d   Chefer, V ^b   Bazov, I ^c   Meis, J ^b   Ogren S O ^a   Shippenberg, T ^b   Bakalkin, G ^c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

^c UPPSALA UNIVERSITY   (Sweden)

^d Enskede Årsta Vantör Socialpsykiatriska Enhet ^*  (Sweden)

Author keywords

Opioid receptor; Alcohol; Dynorphin; Glutamate; Learning; Memory

Indexed keywords

ALCOHOL; DYNORPHIN; GLUTAMIC ACID; KAPPA OPIATE RECEPTOR; NORBINALTORPHIMINE; CENTRAL DEPRESSANT AGENT; DRUG DERIVATIVE; NALTREXONE; NARCOTIC ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINGE DRINKING; COGNITIVE DEFECT; CONTROLLED STUDY; HIPPOCAMPAL CA3 REGION; IN VIVO STUDY; LEARNING DISORDER; MALE; MAZE TEST; MEMORY; MEMORY DISORDER; MICRODIALYSIS; NEUROTRANSMISSION; NONHUMAN; RADIOIMMUNOASSAY; RAT; SPATIAL LEARNING; UPREGULATION; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; HIPPOCAMPUS; LEARNING; METABOLISM; PHYSIOLOGY; SYNAPTIC TRANSMISSION; WISTAR RAT;

ANIMALS; CA3 REGION, HIPPOCAMPAL; CENTRAL NERVOUS SYSTEM DEPRESSANTS; DYNORPHINS; ETHANOL; GLUTAMIC ACID; HIPPOCAMPUS; LEARNING; MAZE LEARNING; MEMORY; MICRODIALYSIS; NALTREXONE; NARCOTIC ANTAGONISTS; RADIOIMMUNOASSAY; RATS; RATS, WISTAR; RECEPTORS, OPIOID, KAPPA; SYNAPTIC TRANSMISSION; UP-REGULATION;

EID: 84885396037     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2013.72     Document Type: Article

References (77)

1. Loeber S, Duka T, Welzel H, Nakovics H, Heinz A, Flor H et al. Impairment of cognitive abilities and decision making after chronic use of alcohol: the impact of multiple detoxifications. Alcohol 2009;44:372-381.
2. Park SQ, Kahnt T, Beck A, Cohen MX, Dolan RJ, Wrase J et al. Prefrontal cortex fails to learn from reward prediction errors in alcohol dependence. J Neurosci 2010;30:7749-7753.
3. Leber WR, Jenkins RL, Parsons OA. Recovery of visual-spatial learning and memory in chronic alcoholics. J Clin Psychol 1981;37:192-197. (Pubitemid 11143354)
4. Oscar-Berman M, Marinkovic K. Alcohol: effects on neurobehavioral functions and the brain. Neuropsychol Rev 2007;17:239-257. (Pubitemid 47498181)
5. Oslin DW, Cary MS. Alcohol-related dementia: validation of diagnostic criteria. Am J Geriatr Psychiatry 2003;11:441-447. (Pubitemid 36807641)
6. Fadda F, Rossetti ZL. Chronic ethanol consumption: from neuroadaptation to neurodegeneration. Prog Neurobiol 1998;56:385-431. (Pubitemid 28404897)
7. Stephens DN, Duka T. Review. Cognitive and emotional consequences of binge drinking: role of amygdala and prefrontal cortex. Philos Trans R Soc Lond B Biol Sci 2008;363:3169-3179.
8. Cippitelli A, Damadzic R, Frankola K, Goldstein A, Thorsell A, Singley E et al. Alcohol-induced neurodegeneration, suppression of transforming growth factorbeta, and cognitive impairment in rats: prevention by group II metabotropic glutamate receptor activation. Biol Psychiatry 2010;67:823-830.
9. Mukamal KJ, Kuller LH, Fitzpatrick AL, Longstreth Jr. WT, Mittleman MA, Siscovick DS. Prospective study of alcohol consumption and risk of dementia in older adults. JAMA 2003;289:1405-1413. (Pubitemid 37430308)
10. Saunders PA, Copeland J R M, Dewey ME, Davidson IA, Mcwilliam C, Sharma V et al. Heavy drinking as a risk factor for depression and dementia in elderly men - findings from the liverpool longitudinal community study. Brit J Psychiat 1991;159:213-216.
11. Jarvenpaa T, Rinne JO, Koskenvuo M, Raiha I, Kaprio J. Binge drinking in midlife and dementia risk. Epidemiology 2005;16:766-771. (Pubitemid 41681543)
12. Brown SA, Tapert SF, Granholm E, Delis DC. Neurocognitive functioning of adolescents: effects of protracted alcohol use. Alcohol Clin Exp Res 2000;24:164-171. (Pubitemid 30117417)
13. Duka T, Gentry J, Malcolm R, Ripley TL, Borlikova G, Stephens DN et al. Consequences of multiple withdrawals from alcohol. Alcohol Clin Exp Res 2004;28:233-246. (Pubitemid 38233601)
14. Colsher PL, Wallace RB. Elderly men with histories of heavy drinking: correlates and consequences. J Stud Alcohol 1990;51:528-535.
15. Crews FT, Boettiger CA. Impulsivity, frontal lobes and risk for addiction. Pharmacol Biochem Behav 2009;93:237-247.
16. Robbins TW, Gillan CM, Smith DG, De Wit S, Ersche KD. Neurocognitive endophenotypes of impulsivity and compulsivity: towards dimensional psychiatry. Trends Cogn Sci 2012;16:81-91.
17. Weisskopf MG, Zalutsky RA, Nicoll RA. The opioid peptide dynorphin mediates heterosynaptic depression of hippocampal mossy fibre synapses and modulates long-term potentiation. Nature 1993;362:423-427. (Pubitemid 23107364)
18. Wagner JJ, Terman GW, Chavkin C. Endogenous dynorphins inhibit excitatory neurotransmission and block LTP induction in the hippocampus. Nature 1993;363:451-454. (Pubitemid 23179391)
19. Sandin J, Nylander I, Georgieva J, Schott PA, Ogren SO, Terenius L. Hippocampal dynorphin B injections impair spatial learning in rats: a kappa-opioid receptormediated effect. Neuroscience 1998;85:375-382. (Pubitemid 28218659)
20. Jiang HK, Owyang VV, Hong JS, Gallagher M. Elevated dynorphin in the hippocampal formation of aged rats: relation to cognitive impairment on a spatial learning task. Proc Natl Acad Sci USA 1989;86:2948-2951. (Pubitemid 19112654)
21. Nguyen XV, Masse J, Kumar A, Vijitruth R, Kulik C, Liu M et al. Prodynorphin knockout mice demonstrate diminished age-associated impairment in spatial water maze performance. Behav Brain Res 2005;161:254-262. (Pubitemid 40732408)
22. Carey AN, Lyons AM, Shay CF, Dunton O, McLaughlin JP. Endogenous kappa opioid activation mediates stress-induced deficits in learning and memory. J Neurosci 2009;29:4293-4300.
23. Kolsch H, Wagner M, Bilkei-Gorzo A, Toliat MR, Pentzek M, Fuchs A et al. Gene polymorphisms in prodynorphin (PDYN) are associated with episodic memory in the elderly. J Neural Transm 2009;116:897-903.
24. Yakovleva T, Marinova Z, Kuzmin A, Seidah NG, Haroutunian V, Terenius L et al. Dysregulation of dynorphins in Alzheimer disease. Neurobiol Aging 2007;28:1700-1708. (Pubitemid 47393586)
25. Bazov I, Kononenko O, Watanabe H, Kuntic V, Sarkisyan D, Taqi MM et al. The endogenous opioid system in human alcoholics: molecular adaptations in brain areas involved in cognitive control of addiction. Addict Biol 2013;18:161-169.
26. Kuzmin A, Liljequist S, Meis J, Chefer V, Shippenberg T, Bakalkin G. Repeated moderate-dose ethanol bouts impair cognitive function in Wistar rats. Addict Biol 2012;17:132-140.
27. Chefer V, Meis J, Wang G, Kuzmin A, Bakalkin G, Shippenberg T. Repeated exposure to moderate doses of ethanol augments hippocampal glutamate neurotransmission by increasing release. Addict Biol 2011;16:229-237.
28. Bedford D, O'Farrell A, Howell F. Blood alcohol levels in persons who died from accidents and suicide. Ir Med J. 2006;99:80-83.
29. Jones AW. Ultra-rapid rate of ethanol elimination from blood in drunken drivers with extremely high blood-alcohol concentrations. Int J Legal Med 2008;122:129-134. (Pubitemid 351170121)
30. Lamminpaa A, Hoppu K. First-order alcohol elimination in severe alcohol intoxication in an adolescent: a case report. Am J Emerg Med 2009;27:128 e5-6.
31. Majchrowicz E. Induction of physical-dependence upon ethanol and associated behavioral-changes in rats. Psychopharmacologia 1975;43:245-254.
32. Faingold CL. The Majchrowicz binge alcohol protocol: an intubation technique to study alcohol dependence in rats. Curr Protoc Neurosci 2008; Chapter 9: Unit 9 28.
33. Obernier JA, White AM, Swartzwelder HS, Crews FT. Cognitive deficits and CNS damage after a 4-day binge ethanol exposure in rats. Pharmacol Biochem Behav 2002;72:521-532. (Pubitemid 34450852)
34. Dahchour A, De Witte P. Effect of repeated ethanol withdrawal on glutamate microdialysate in the hippocampus. Alcohol Clin Exp Res 1999;23:1698-1703. (Pubitemid 29498657)
35. Paxinos G, Watson C (eds.). The rat brain in stereotaxic coordinates. Fourth Edition. Academic Press: New York, USA, 1998.
36. Ogren SO, Kehr J, Schott PA. Effects of ventral hippocampal galanin on spatial learning and on in vivo acetylcholine release in the rat. Neuroscience 1996;75:1127-1140. (Pubitemid 26377098)
37. Horan P, Taylor J, Yamamura HI, Porreca F. Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail-flick test. J Pharmacol Exp Ther 1992;260:1237-1243.
38. Jones D N C, Holtzman SG. Long-term kappa-opioid receptor blockade following nor-binaltorphimine. Eur J Pharmacol 1992;215:345-348.
39. Broadbear JH, Negus SS, Butelman ER, De Costa BR, Woods JH. Differential effects of systemically administered nor-binaltorphimine (nor-BNI) on kappaopioid agonists in the mouse writhing assay. Psychopharmacology (Berl) 1994;115:311-319. (Pubitemid 24217089)
40. Chang AC, Takemori AE, Portoghese PS. 2-(3, 4-Dichlorophenyl)-N-Methyl-N- [ (1s) 1-(3-Isothiocyanatophenyl)-2-(1-Pyrrolidinyl) ethyl]acetamide - an opioid receptor affinity label that produces selective and long-lasting kappa antagonism in mice. J Med Chem 1994;37:1547-1549. (Pubitemid 24195465)
41. Kuzmin A, Sandin J, Terenius L, Ogren SO. Dose-and time-dependent bimodal effects of kappa-opioid agonists on locomotor activity in mice. J Pharmacol Exp Ther 2000;295:1031-1042.
42. Chefer VI, Thompson AC, Zapata A, Shippenberg TS. Overview of brain microdialysis. Curr Protoc Neurosci 2009; Chapter 7: Unit7 1.
43. Christensson-Nylander I, Nyberg F, Ragnarsson U, Terenius L. A general procedure for analysis of proenkephalin B derived opioid peptides. Regul Pept 1985;11:65-76. (Pubitemid 15042837)
44. D'Hooge R, De Deyn PP. Applications of the Morris water maze in the study of learning and memory. Brain Res Brain Res Rev 2001;36:60-90. (Pubitemid 32763130)
45. Langston RF, Stevenson CH, Wilson CL, Saunders I, Wood ER. The role of hippocampal subregions in memory for stimulus associations. Behav Brain Res 2010;215:275-291.
46. Gilbert PE, Brushfield AM. The role of the CA3 hippocampal subregion in spatial memory: a process oriented behavioral assessment. Prog Neuropsychopharmacol Biol Psychiatry 2009;33:774-781.
47. Kesner RP. Behavioral functions of the CA3 subregion of the hippocampus. Learn Mem 2007;14:771-781. (Pubitemid 350172775)
48. Taqi MM, Bazov I, Watanabe H, Sheedy D, Harper C, Alkass K et al. Prodynorphin CpG-SNPs associated with alcohol dependence: elevated methylation in the brain of human alcoholics. Addict Biol 2011;16:499-509.
49. Drake CT, Terman GW, Simmons ML, Milner TA, Kunkel DD, Schwartzkroin PA et al. Dynorphin opioids present in dentate granule cells may function as retrograde inhibitory neurotransmitters. J Neurosci 1994;14:3736-3750. (Pubitemid 24174120)
50. Terman GW, Drake CT, Simmons ML, Milner TA, Chavkin C. Opioid modulation of recurrent excitation in the hippocampal dentate gyrus. J Neurosci 2000;20:4379-4388. (Pubitemid 30396602)
51. Faden AI. Dynorphin increases extracellular levels of excitatory amino acids in the brain through a non-opioid mechanism. J Neurosci 1992;12:425-429.
52. Skilling SR, Sun X, Kurtz HJ, Larson AA. Selective potentiation of NMDA-induced activity and release of excitatory amino acids by dynorphin: possible roles in paralysis and neurotoxicity. Brain Res 1992;575:272-278.
53. Hjelmstad GO, Fields HL. Kappa opioid receptor activation in the nucleus accumbens inhibits glutamate and GABA release through different mechanisms. J Neurophysiol 2003;89:2389-2395. (Pubitemid 36570203)
54. Crain SM, Shen KF. Modulation of opioid analgesia, tolerance and dependence by G (s)-coupled, GM1 ganglioside-regulated opioid receptor functions. Trends Pharmacol Sci 1998;19:358-365. (Pubitemid 28458832)
55. Rivera M, Gintzler AR. Differential effect of chronic morphine on mRNA encoding adenylyl cyclase isoforms: relevance to physiological sequela of tolerance/dependence. Mol Brain Res 1998;54:165-169. (Pubitemid 28119173)
56. Gruol DL, Chavkin C, Valentino RJ, Siggins GR. Dynorphin-A alters the excitability of pyramidal neurons of the rat hippocampus in vitro. Life Sci 1983;33(Suppl 1):533-536. (Pubitemid 14250003)
57. Moore SD, Madamba SG, Schweitzer P, Siggins GR. Voltage-dependent effects of opioid peptides on hippocampal CA3 pyramidal neurons in vitro. J Neurosci 1994;14:809-820. (Pubitemid 24043933)
58. McDermott CM, Schrader LA. Activation of kappa opioid receptors increases intrinsic excitability of dentate gyrus granule cells. J Physiol 2011;589(Pt 14):3517-3532.
59. Karst H, Berger S, Turiault M, Tronche F, Schutz G, Joels M. Mineralocorticoid receptors are indispensable for nongenomic modulation of hippocampal glutamate transmission by corticosterone. Proc Natl Acad Sci USA 2005;102:19204-19207. (Pubitemid 43049590)
60. Yang CH, Huang CC, Hsu KS. Behavioral stress enhances hippocampal CA1 longterm depression through the blockade of the glutamate uptake. J Neurosci 2005;25:4288-4293.
61. Wong TP, Howland JG, Robillard JM, Ge Y, Yu W, Titterness AK et al. Hippocampal long-term depression mediates acute stress-induced spatial memory retrieval impairment. Proc Natl Acad Sci USA 2007;104:11471-11476. (Pubitemid 47175164)
62. Katagiri H, Tanaka K, Manabe T. Requirement of appropriate glutamate concentrations in the synaptic cleft for hippocampal LTP induction. Eur J Neurosci 2001;14:547-553. (Pubitemid 34203462)
63. Harper C, Dixon G, Sheedy D, Garrick T. Neuropathological alterations in alcoholic brains. Studies arising from the New South Wales Tissue Resource Centre. Prog Neuropsychopharmacol Biol Psychiatry 2003;27:951-961. (Pubitemid 37142503)
64. Miguel-Hidalgo JJ, Overholser JC, Meltzer HY, Stockmeier CA, Rajkowska G. Reduced glial and neuronal packing density in the orbitofrontal cortex in alcohol dependence and its relationship with suicide and duration of alcohol dependence. Alcohol Clin Exp Res 2006;30:1845-1855. (Pubitemid 44630086)
65. Kril JJ, Halliday GM, Svoboda MD, Cartwright H. The cerebral cortex is damaged in chronic alcoholics. Neuroscience 1997;79:983-998. (Pubitemid 27293752)
66. Walker DW, Freund G. Impairment of shuttle box avoidance learning following prolonged alcohol consumption in rats. Physiol Behav 1971;7:773-778.
67. Arendt T, Allen Y, Sinden J, Schugens MM, Marchbanks RM, Lantos PL et al. Cholinergic-rich brain transplants reverse alcohol-induced memory deficits. Nature 1988;332:448-450. (Pubitemid 18090246)
68. Melis F, Stancampiano R, Imperato A, Carta G, Fadda F. Chronic ethanol consumption in rats: correlation between memory performance and hippocampal acetylcholine release in vivo. Neuroscience 1996;74:155-159. (Pubitemid 26291155)
69. Chavkin C. Dynorphin-still an extraordinarily potent opioid peptide. Mol Pharmacol 2013;83:729-736.
70. Robbins TW, Ersche KD, Everitt BJ. Drug addiction and the memory systems of the brain. Ann N Y Acad Sci 2008;1141:1-21.
71. Hyman SE, Malenka RC, Nestler EJ. Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 2006;29:565-598. (Pubitemid 44476856)
72. Xuei X, Dick D, Flury-Wetherill L, Tian HJ, Agrawal A, Bierut L et al. Association of the kappa-opioid system with alcohol dependence. Mol Psychiatry 2006;11:1016-1024. (Pubitemid 44631644)
73. Edenberg HJ, Wang J, Tian HJ, Pochareddy S, Xuei XL, Wetherill L et al. A regulatory variation in OPRK1, the gene encoding the kappa-opioid receptor, is associated with alcohol dependence. Hum Mol Genet 2008;17:1783-1789. (Pubitemid 351791504)
74. Karpyak VM, Winham SJ, Preuss UW, Zill P, Cunningham JM, Walker DL et al. Association of the PDYN gene with alcohol dependence and the propensity to drink in negative emotional states. Int J Neuropsychopharmacol 2013;16:975-985.
75. Walker BM, Koob GF. Pharmacological evidence for a motivational role of kappaopioid systems in ethanol dependence. Neuropsychopharmacology 2008;33:643-652.
76. Kissler JL, Sirohi S, Reis DJ, Jansen HT, Quock RM, Smith DG et al. The one-two punch of alcoholism: role of central amygdala dynorphins/kappa-opioid receptors. Biol Psychiatry 2013, e-pub 2013/04/25.
77. Walker BM, Kissler JL. Dissociable effects of kappa-opioid receptor activation on impulsive phenotypes in Wistar rats. Neuropsychopharmacology 2013; e-pub 2013/05/22.